A Study of NP-201 Acetate Injection in Healthy Adult Volunteers and in Patients With Mild-To-Moderate Active Ulcerative Colitis

Summary

This Phase 1b/2a clinical development plan is focused on the use of NP-201 acetate injection to investigate the pharmacokinetics (PK), safety, efficacy, PD (pharmacodynamic) markers (Phase 1b) and tolerability of NP-201 acetate injection after subcutaneous (SC) injection of multiple doses in healthy adults and in the ulcerative colitis (UC) patient population.

Timeline

Start

2024-11-25

Primary completion

2025-07-18

Completion

2025-09-04

Outcome

Outcome not reported

Stopped (Business): “Study was terminated at the end of Part A for strategic reasons (not due to lack of efficacy or safety issues”

Drugs

Indications